Next Article in Journal
In Vitro Activity of a Novel Siderophore-Cephalosporin LCB10-0200 (GT-1), and LCB10-0200/Avibactam, against Carbapenem-Resistant Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa Strains at a Tertiary Hospital in Korea
Previous Article in Journal
Checkpoint Inhibitor-Induced Colitis—A Clinical Overview of Incidence, Prognostic Implications and Extension of Current Treatment Options
 
 
Review

Article Versions Notes

Pharmaceuticals 2021, 14(4), 369; https://doi.org/10.3390/ph14040369
Action Date Notes Link
article xml file uploaded 16 April 2021 09:45 CEST Original file -
article xml uploaded. 16 April 2021 09:45 CEST Update https://www.mdpi.com/1424-8247/14/4/369/xml
article pdf uploaded. 16 April 2021 09:45 CEST Version of Record https://www.mdpi.com/1424-8247/14/4/369/pdf
article html file updated 16 April 2021 09:47 CEST Original file -
article html file updated 25 July 2022 12:28 CEST Update https://www.mdpi.com/1424-8247/14/4/369/html
Back to TopTop